The Dubai social media advertising rule is four years old, and the August 2026 circular is the regulator telling you it is now looking.
On 17 August 2026 the Dubai Health Authority circulated the Standards for Medical Advertisement Content on Social Media to all licensed private-sector facilities and healthcare professionals. The standard itself, DHA/HRS/HPSD/ST-21, took effect on 3 October 2022. Its prohibited list covers before-and-after images without a variability disclaimer, patient testimonials without written consent, treatments that guarantee full recovery, claims of exclusive unique skill, and filming a patient under general anaesthesia for marketing. A regulator re-circulating a four-year-old rule is usually signalling what it intends to start checking.
What a board member needs before the next meeting on this.
- The rule is older than the circular announcing it. The standard carries code DHA/HRS/HPSD/ST-21, version 1.1, issue date 3 August 2022 and effective date 3 October 2022, with a revision date of 3 August 2027. Content published at any point since October 2022 has been inside its scope.
- Before-and-after images require a disclaimer to be compliant. Visual before-and-after images are prohibited where they do not carry a disclaimer that outcomes may vary between patients, and the images must represent only patients who actually received the treatment advertised.
- Testimonials need written patient consent. Patient testimonials without written consent are prohibited, as is any patient-identifiable information. For a clinic whose acquisition funnel runs on reviews and case stories, the consent file is the compliance evidence.
- The obligation reaches the individual professional and the medical director. The standard runs to five parts, with separate sections on the responsibilities of medical directors and of healthcare professionals. Exposure sits on the named individual as well as on the facility licence.
On 17 August 2026 the Dubai Health Authority's Health Regulation Sector circulated the Standards for Medical Advertisement Content on Social Media to all licensed health facilities and healthcare professionals in the Dubai private sector, under reference CIR-2026-00000144 (DHA circular CIR-2026-00000144; DHA circulars index).
The document attached to that circular carries code DHA/HRS/HPSD/ST-21, version 1.1, an issue date of 3 August 2022 and an effective date of 3 October 2022. The standard has bound every DHA-licensed clinic in Dubai for close to four years. That is the story: when a regulator re-circulates a rule that has been in force since 2022, it is usually telling the market where it intends to look next.
The prohibited list is specific, and it describes ordinary clinic content
Appendix 2 of the standard lists what may not appear in a social media medical advertisement. Treatments that guarantee full recovery are prohibited. So are unrealistic, absolute or unwarranted statements about the effectiveness of a treatment, device or medicine. Patient testimonials without written patient consent are prohibited, as is any patient-identifiable information. Comparisons against another treatment, device or medicine are prohibited unless scientifically proven through peer review and supported by credible references.
Terms implying that a professional has an exclusive unique skill, or that results are always effective, are prohibited. Content that causes fear, anxiety, panic or distress, or leads the public to believe they suffer from a serious or infectious disease, is prohibited. Read that list against the Instagram grid of a typical Dubai aesthetic or dermatology practice and the overlap is not marginal.
Before and after images are permitted, conditionally
The standard does not ban before-and-after imagery, which is the single most common format in the sector. It conditions it. Visual before-and-after images are prohibited where they do not include a disclaimer that the outcome of the treatment, device or medicine may vary from one patient to another, and the images must only represent patients who have actually received the treatment being advertised.
Both halves matter. The disclaimer is a content fix that can be applied going forward and retrospectively. The second requirement is an evidence question: a clinic using stock or manufacturer-supplied imagery in a post promoting its own service cannot satisfy it, and cannot fix it with a caption.
Theatre footage is prohibited outright
The list closes with a prohibition that admits no disclaimer. All forms of video filming for health advertisement while a patient is undergoing surgery under general anaesthesia are prohibited where the purpose is promotion of the health facility, physician, dentist, nurse or allied healthcare professional online or through social media. Surgical content is a recognised acquisition format in cosmetic and bariatric practice across the region. Under this standard, if the patient was under general anaesthesia and the footage was used for marketing, there is no compliant version of that post.
Why this becomes a diligence item
Marketing exposure in healthcare is usually treated as a spend line and a brand question. This standard puts it on the licence. The document assigns explicit responsibilities to medical directors in one section and to healthcare professionals in another, so a breach can attach to a named individual's licence as well as to the facility's.
Its first section governs the social media accounts themselves rather than only the posts on them, which means the question of who owns and operates a clinic's channels is inside scope. Practices that run acquisition through an agency account, or through the personal profile of a star clinician, should establish which licensed entity the regulator will hold responsible for it.
Historic content is durable and discoverable: a post from 2023 remains published, remains inside the standard's scope, and remains visible to an inspector or a competitor. For a buyer, the marketing archive is therefore a place to look before signing, and the remediation is straightforward to scope once someone actually looks. For a seller, the growth story that rests on a high-performing social funnel is worth checking against a rule the funnel may never have been built to satisfy.
Four questions for a Dubai clinic with a marketing budget
- Does every before-and-after image currently published carry a variability disclaimer, and can the clinic evidence that each image shows a patient who received the advertised treatment?
- For every patient testimonial and case story online, is there a signed written consent on file, and does the retention of that consent match the period the content stays published?
- Has any content been filmed in theatre while a patient was under general anaesthesia, and if so, was it used to promote the facility or a named professional?
- Who inside the practice approves social content before it publishes, and does that person hold the medical director responsibility the standard assigns?
The Monday work is finite. Export the clinic's published social content since October 2022 and screen it against Appendix 2, starting with before-and-after posts missing a variability disclaimer, testimonials with no signed consent on file, and any theatre footage. Establish who approves content before it publishes and whether that person carries the medical director responsibility the standard assigns. Then decide what comes down, what gets a disclaimer, and what needs a consent obtained retrospectively. That regulatory and governance work is where our strategic advisory practice begins.
This brief covers one instrument. The UAE healthcare regulatory tracker carries the full set — DoH, DHA, EDE and the other emirates — with what each one changes and when it takes effect.
Subscribe
The UAE healthcare regulatory briefing
What changed, what it reprices, and the instrument to read. Every second Tuesday. No pitches.
One email a fortnight. Unsubscribe from any of them.